[go: up one dir, main page]

PL2576768T3 - Oczyszczanie niehodowanych komórek macierzystych galarety Whartona - Google Patents

Oczyszczanie niehodowanych komórek macierzystych galarety Whartona

Info

Publication number
PL2576768T3
PL2576768T3 PL11725570T PL11725570T PL2576768T3 PL 2576768 T3 PL2576768 T3 PL 2576768T3 PL 11725570 T PL11725570 T PL 11725570T PL 11725570 T PL11725570 T PL 11725570T PL 2576768 T3 PL2576768 T3 PL 2576768T3
Authority
PL
Poland
Prior art keywords
purification
stem cells
jelly stem
native wharton
wharton
Prior art date
Application number
PL11725570T
Other languages
English (en)
Inventor
Rouzbeh R Taghizadeh
Original Assignee
Auxocell Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auxocell Laboratories Inc filed Critical Auxocell Laboratories Inc
Publication of PL2576768T3 publication Critical patent/PL2576768T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
PL11725570T 2010-06-01 2011-06-01 Oczyszczanie niehodowanych komórek macierzystych galarety Whartona PL2576768T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35030310P 2010-06-01 2010-06-01
EP11725570.3A EP2576768B1 (en) 2010-06-01 2011-06-01 Native wharton's jelly stem cells and their purification
PCT/US2011/038710 WO2011153205A1 (en) 2010-06-01 2011-06-01 Native wharton's jelly stem cells and their purification

Publications (1)

Publication Number Publication Date
PL2576768T3 true PL2576768T3 (pl) 2017-10-31

Family

ID=44225995

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11725570T PL2576768T3 (pl) 2010-06-01 2011-06-01 Oczyszczanie niehodowanych komórek macierzystych galarety Whartona

Country Status (12)

Country Link
US (6) US20130121972A1 (pl)
EP (1) EP2576768B1 (pl)
BR (1) BR112012030678B1 (pl)
CA (2) CA2801009C (pl)
CY (1) CY1119382T1 (pl)
DK (1) DK2576768T3 (pl)
ES (1) ES2634545T3 (pl)
LT (1) LT2576768T (pl)
PL (1) PL2576768T3 (pl)
PT (1) PT2576768T (pl)
SG (1) SG185811A1 (pl)
WO (1) WO2011153205A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2664337B1 (en) 2005-09-27 2019-08-14 TissueTech, Inc. Amniotic membrane preparations and purified compositions and methods of use
SG185811A1 (en) 2010-06-01 2013-01-30 Auxocell Lab Inc Native wharton's jelly stem cells and their purification
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
WO2012170905A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
SG11201501024QA (en) * 2012-08-15 2015-03-30 Univ Singapore Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
KR20160121547A (ko) 2014-02-11 2016-10-19 코닝 인코포레이티드 안정화된 리튬 복합 입자들을 포함한 리튬 이온 배터리들
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
USD748462S1 (en) 2014-08-11 2016-02-02 Auxocell Laboratories, Inc. Centrifuge clip
US9993748B2 (en) 2014-08-11 2018-06-12 Auxocell Laboratories, Inc. Centrifuge clip and method
TW201642914A (zh) 2015-02-23 2016-12-16 組織科技股份有限公司 用於治療眼部疾病及失調的裝置及方法
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
EP3423119A4 (en) 2016-03-04 2020-02-19 The Board of Regents of The University of Texas System DEVICES AND METHODS FOR TREATING OMBILICAL CORD
AU2018228352B2 (en) * 2017-02-28 2024-08-01 Centre Hospitalier Régional Universitaire De Nancy Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis
US11723635B2 (en) 2017-09-05 2023-08-15 The Board Of Regents Of The University Of Texas System Devices and methods for umbilical cord processing
EP3909593A1 (en) 2020-05-15 2021-11-17 Rigshospitalet Stem cells for treating skin lesions

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
IT1260682B (it) 1993-09-28 1996-04-22 Consult T S S N C Di Roggero G Dispositivo trituratore meccanico di materiale biologico
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
PT1062321E (pt) 1998-03-13 2005-05-31 Osiris Therapeutics Inc Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
US6835377B2 (en) 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
PT1082410E (pt) 1998-05-29 2007-11-09 Osiris Therapeutics Inc Células estaminais mesenquimatosas humanas cd45+ e/ou fibroblastos+
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
WO2004069172A2 (en) 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
EP1594957B1 (en) 2003-02-11 2010-08-25 John E. Davies Progenitor cells from wharton's jelly of human umbilical cord
US7794408B2 (en) 2003-03-28 2010-09-14 Ethicon, Inc. Tissue collection device and methods
TWI255738B (en) 2003-12-31 2006-06-01 Ind Tech Res Inst Tissue pulverizer
CN101575590B (zh) * 2005-02-28 2012-05-23 中国医学科学院血液学研究所泰达生命科学技术研究中心 人脐带间充质干细胞的制备方法
CN100344757C (zh) * 2005-10-18 2007-10-24 天津昂赛细胞基因工程有限公司 人胎盘、脐带间充质干细胞库及其构建方法
US20080019949A1 (en) * 2006-06-28 2008-01-24 University Of Kansas Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
US20080118477A1 (en) * 2006-11-09 2008-05-22 Rush University Medical Center Umbilical cord mesenchymal stem cells support cord blood hematopoiesis
CA2677397C (en) 2007-02-12 2016-04-05 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US20090074731A1 (en) * 2007-09-13 2009-03-19 Librach Clifford L Method of isolation and use of cells derived from first trimester umbilical cord tissue
PT103843B (pt) 2007-10-04 2008-08-12 Medinfar Produtos Farmaceutico Método de isolamento de células precursoras a partir do cordão umbilical humano
UA99152C2 (ru) 2007-10-05 2012-07-25 Этикон, Инкорпорейтед Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
CA2736353A1 (en) 2008-08-04 2010-02-11 Allocure Mesenchymal stromal cell populations and methods of isolating and using same
ES2670932T3 (es) * 2008-10-10 2018-06-04 Histocell S.L. Nuevo biomaterial a partir de la gelatina de Wharton del cordón umbilical humano
US20100111908A1 (en) 2008-11-03 2010-05-06 Fangming Lin Induction of Renal Cells for Treatment of Kidney Disease
CN101629165B (zh) * 2009-07-24 2012-12-26 中国人民解放军海军总医院 一种原始间充质干细胞的制备方法
CN101643719B (zh) * 2009-07-27 2013-07-24 北京大学人民医院 一种简化的脐带间充质干细胞分离培养方法及其在类风湿关节炎治疗中的应用
CN101642469B (zh) * 2009-09-09 2012-05-23 中国人民解放军海军总医院 脐带华通胶来源的间充质干细胞在急性心肌梗死细胞移植治疗中的应用
US20120276070A1 (en) 2009-11-17 2012-11-01 Vitro Diagnositics, Inc. Induced Pluripotent Stem Cells and Related Methods
AU2010332777A1 (en) 2009-12-18 2012-07-19 C.B.B. Lifeline Biotech Ltd. Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue
SG185811A1 (en) 2010-06-01 2013-01-30 Auxocell Lab Inc Native wharton's jelly stem cells and their purification
KR101210988B1 (ko) 2010-06-08 2012-12-11 동국대학교 산학협력단 전자기장을 이용한 성체 줄기세포의 신경세포 분화유도 방법
WO2012131618A1 (en) 2011-03-30 2012-10-04 Stempeutics Research Private Limited A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof
TWI535377B (zh) 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
CA2862437C (en) 2011-11-08 2018-07-03 Auxocell Laboratories, Inc. Tissue mincing tool and methods of use thereof

Also Published As

Publication number Publication date
US20200332261A1 (en) 2020-10-22
LT2576768T (lt) 2017-08-25
US20150197728A1 (en) 2015-07-16
CA2801009A1 (en) 2011-12-08
PT2576768T (pt) 2017-08-11
US9012222B2 (en) 2015-04-21
WO2011153205A1 (en) 2011-12-08
DK2576768T3 (en) 2017-08-28
ES2634545T3 (es) 2017-09-28
EP2576768B1 (en) 2017-05-10
CA3056049A1 (en) 2011-12-08
US9441201B2 (en) 2016-09-13
US20170044490A1 (en) 2017-02-16
US20130121972A1 (en) 2013-05-16
EP2576768A1 (en) 2013-04-10
BR112012030678A2 (pt) 2017-07-25
SG185811A1 (en) 2013-01-30
US20130183273A1 (en) 2013-07-18
CA2801009C (en) 2021-10-26
US9920301B2 (en) 2018-03-20
BR112012030678B1 (pt) 2021-10-19
US20170107496A1 (en) 2017-04-20
CY1119382T1 (el) 2018-02-14

Similar Documents

Publication Publication Date Title
PL2576768T3 (pl) Oczyszczanie niehodowanych komórek macierzystych galarety Whartona
ZA201804932B (en) Materials and methods to enhance hematopoietic stem cells engraftment procedures
PL2606120T3 (pl) Ludzkie komórki ułatwiające tolerancję i ich zastosowanie
GB2450603B (en) Human pluripotent stem cells and their medical use
ZA201001158B (en) Diferentiation of human embryonic stem cells
EP2432462A4 (en) OXYGEN PROCEDURE AND COMPOSITIONS FOR THE TREATMENT OF MAMMALIAN DISEASES
PT3578988T (pt) Método de diferenciação de nocicetor de células estaminais embrionárias humanas e utilizações do mesmo
GB201202848D0 (en) Differemtiaiotn of human embryonic stem cells
WO2010111409A3 (en) Pluripotent stem cells
ZA201207331B (en) Concentrated protein formulations and uses thereof
IL195826A0 (en) Placental niche and use thereof to culture stem cells
ZA201203805B (en) Use of layer superstructures in wind power plants
GB2474083B (en) Improvements in and relating to ophthalmic instruments
EP2370093A4 (en) NEUREGULIN AND CARDIAC STEM CELLS
EP2227540A4 (en) DIFFERENTIATION OF HUMAN CELLS
PL2913395T3 (pl) Nowa ciągła ludzka linia komórkowa
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
WO2012040456A3 (en) Human b1 cells and uses thereof
GB2498917B (en) Improvements in and relating to wearable supports
GB0902538D0 (en) Improvvements in or relating to the creation of curved forms
GB201019999D0 (en) Improvements in or relating to the retention of bearings
GB2449466B (en) Production of proteins in plant tissue
SG10201504220YA (en) Method for inducing pluripotency in human somatic cells with prdm14 or nfrkb
AP3351A (en) Extracellular plant ferredoxin-like protein and uses thereof
GB2474082B (en) Improvements in and relating to ophthalmic instruments